Completed PHASE4 INTERVENTIONAL 1-arm NCT01885091

Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage

Kinerase® Interactive Skin-care Study: A Multicentre, Phase IV, Single-arm, Open-label Trial to Evaluate the Efficacy and Safety of Kinetin, N6-furfuryladenine, 0.1% for Treatment of Cutaneous Facial Photodamage

Sponsor: Menarini (Thailand) Limited

Conditions Blotchiness Fine Wrinkles Mottling Pigmentation Skin Roughness

Interventions Kinerase

Updated 5 times since 2017 Last updated: Jun 23, 2013 Started: Dec 31, 2012 Primary completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01885091, this PHASE4 trial focuses on Blotchiness and Fine Wrinkles and remains completed. Sponsored by Menarini (Thailand) Limited, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Menarini (Thailand) Limited

Data source: Menarini (Thailand) Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand